Résumé
INTRODUCCIÓN La infección periprotésica (IPP) es una de las complicaciones más serias en una artroplastia total de rodilla (ATR). Pese a esto, existe poca literatura chilena respecto de esta patología. OBJETIVOS Determinar la incidencia, las comorbilidades, los microorganismos aislados y su susceptibilidad antibiótica, y la morbimortalidad en pacientes con IPP. MATERIALES Y MÉTODOS Estudio descriptivo y retrospectivo en pacientes operados entre 2001 y 2020 por gonartrosis, con una ATR primaria, en un mismo centro de salud, con al menos 1 año de seguimiento. Se excluyeron pacientes operados en otros centros o con registros clínicos incompletos. Se registraron las comorbilidades, los microorganismos aislados, la susceptibilidad antibiótica, y la sobrevida por medio de una búsqueda sistemática de las fichas clínicas de los pacientes con IPP. Se utilizó estadística descriptiva para presentar los datos. RESULTADOS Se incluyeron 544 ATRs, de las cuales 8 (1,47%) presentaron IPP, y los pacientes tenían una edad promedio de presentación de 66 (±5,7) años, e índice de masa corporal (IMC) promedio de 30,3 (±4,5) kg/m2. La mediana de tiempo de presentación de la IPP fue de 411 (±1.034) días. Las principales comorbilidades registradas fueron hipertensión arterial en 5 (62,5%), tabaquismo en 4 (50%) casos, y dislipidemia in 4 (50%) casos. En total, 5 (62,5%) pacientes presentaron etiología polimicrobiana, y en 3 (37,5%) se aisló un solo microorganismo. Los principales agentes aislados fueron Staphylococcus aureus y Staphylococcus coagulasa negativo, ambos multirresistentes, en 6 (75%) y 3 (37,5%) pacientes respectivamente. Todos los pacientes recibieron tres dosis de cefazolina como profilaxis quirúrgica. Se describe una sensibilidad del 100% frente a vancomicina y rifampicina (12/12 cultivos), y una resistencia del 83,4% al ciprofloxacino (4/9 cultivos). Un total de 2 (25%) pacientes fallecieron después de 3 años de la ATR por causas no relacionadas con la IPP. No hubo casos de recidiva infecciosa tras la revisión. CONCLUSIÓN Se encontró una incidencia de 1,47% (8 casos) de IPP. Todos los pacientes con IPP presentaron alguna comorbilidad prequirúrgica. Los principales agentes microbiológicos identificados fueron multirresistentes y susceptibles a vancomicina y rifampicina.
INTRODUCTION Periprosthetic infection (PPI) is one of the most serious complications in total knee arthroplasty (TKA). Despite this, there is little Chilean literature regarding this pathology. OBJETIVES To determine the incidence, comorbidities, isolated microorganisms and their antibiotic susceptibility, morbidity, and mortality in patients with PPI. MATERIALS AND METHODS A descriptive and retrospective study in patients operated between 2001 and 2020 for gonarthrosis, with a primary TKA, in the same health center, with at least 1 year of follow-up. Patients operated on in other centers or with incomplete clinical records were excluded. Comorbidities, isolated microorganisms, antibiotic susceptibility, and survival were recorded through a systematic search of the clinical records of patients with PPI. Descriptive statistics were used to present the data. RESULTS We included 544 TKAs, 8 (1.47%) of which presented PPI, and the patients had an average age at presentation of 66 years ( 5.7 years) and an average body mass index (BMI) of 30.3 ( 4, 5) kg/m2 . The median time of presentation of the PPI was of 411 ( 1,034) days. The main comorbidities recorded were arterial hypertension in 5 (62.5%), smoking in 4 (50%) cases, and dyslipidemia in 4 (50%) cases. In total, 5 (62.5%) patients presented polymicrobial etiology, and in 3 (37.5%), a single microorganism was isolated. The main isolated agents were Staphylococcus aureus and coagulasenegative Staphylococcus, both multidrug-resistant, in 6 (75%) and 3 (37.5%) patients respectively. All patients received three doses of cefazolin as surgical prophylaxis. A sensitivity of 100% to vancomycin and rifampicin (12/12 cultures), and a resistance of 83.4% to ciprofloxacin (4/9 cultures) were described. Overall, 2 (25%) patients died 3 years after the TKA, due to causes unrelated to PPI. There were no cases of infectious relapse after the review. CONCLUSION An incidence of 1.47% (8 cases) of PPI was found. All patients with PPI presented some presurgical comorbidity. The main microbiological agents identified were multidrug-resistant and susceptible to vancomycin and rifampicin
Sujets)
Humains , Mâle , Femelle , Trouble lié au tabagisme/épidémiologie , Infections dues aux prothèses/épidémiologie , Arthroplastie prothétique de genou/effets indésirables , Diabète/épidémiologie , Hypertension artérielle/épidémiologie , Staphylococcus aureus/isolement et purification , Comorbidité , Céfazoline/usage thérapeutique , Chili/épidémiologie , Épidémiologie Descriptive , Incidence , Infections dues aux prothèses/traitement médicamenteux , Antibactériens/usage thérapeutiqueRésumé
Bone cement, consisting of polymethyl methacrylate, is a bioinert material used for prothesis fixation in joint arthroplasty. To treat orthopedic infections, such as periprosthetic joint infection, antibiotic-loaded bone cement (ALBC) was introduced into clinical practice. Recent studies have revealed the limitations of the antibacterial effect of ALBC. Moreover, with the increase in high infection risk patients and highly resistant microbes, more researches and modification of ALBC are required. This paper reviewed latest findings about ALBC for most popular and destructive pathogens, summarized the influence of antibiotic kind, drug dosage, application method, and environment towards characteristic of ALBC. Subsequently, new cement additives and clinical applications of ALBC in joint arthroplasty were also discussed.
Sujets)
Humains , Antibactériens/usage thérapeutique , Arthroplastie prothétique de genou , Ciments osseux , Poly(méthacrylate de méthyle) , Infections dues aux prothèses/traitement médicamenteuxRésumé
ABSTRACT Backgroud: Daptomycin has been used in bone and joint infections (BJI) and prosthesis joint infections (PJI) considering spectrum of activity and biofilm penetration. However, the current experience is based on case reports, case series, cohorts, and international surveys. The aim of this systematic review was to evaluate studies about daptomycin treatment efficacy in BJI/PJI compared to other antibiotic regimens. Methods: PubMed, LILACS, Scielo and Web of Science databases were searched for articles about daptomycin and treatment of BJI and PJI from inception to March 2018. Inclusion criteria were any published researches that included patients with BJI treated with daptomycin. Diagnosis of BJI was based on clinical, laboratory and radiological findings according to IDSA guidelines. Results: From 5107 articles, 12 articles were included. Only three studies described the outcomes of patients with BJI treated with daptomycin with comparator regimen (vancomycin, teicoplanin and oxacillin). Studies presented large heterogeneity regarding device related infections, surgical procedures, and daptomycin regimens (varied from 4 mg/kg to 10 mg/kg). A total of 299 patients have been included in all studies (184 infections associated with orthopedic disposal and 115 osteomyelitis/septic arthritis). Two hundred and thirty-three patients were treated with daptomycin. The clinical cure rates on device related and non-device related infections (i.e. osteomyelitis) were 70% and 78%, respectively. Compared to all regimens evaluated, daptomycin group outcomes were non-inferior. Conclusion: Although a randomized clinical trial is needed, this systematic review tends to support daptomycin usage for bone and joint infections.
Sujets)
Humains , Maladies osseuses/traitement médicamenteux , Infections dues aux prothèses/traitement médicamenteux , Daptomycine/usage thérapeutique , Maladies articulaires/traitement médicamenteux , Antibactériens/usage thérapeutique , Ostéomyélite/traitement médicamenteux , Arthrite infectieuse/traitement médicamenteux , Prothèse articulaire/effets indésirablesSujets)
Humains , Mâle , Adulte d'âge moyen , Infections dues aux prothèses/complications , Infections à staphylocoques/complications , Tachycardie ventriculaire/diagnostic , Acétamides/usage thérapeutique , Anti-infectieux/usage thérapeutique , Oxazolidinones/usage thérapeutique , Infections dues aux prothèses/traitement médicamenteux , Récidive , Staphylococcus aureus , Staphylococcus epidermidis , Infections à staphylocoques/traitement médicamenteux , Facteurs temps , Résultat thérapeutiqueSujets)
Antibactériens , Arthroplastie prothétique de hanche/effets indésirables , Programme d'études , Déontologie médicale , Humains , Inde , Santé au travail/statistiques et données numériques , Infections dues aux prothèses/traitement médicamenteux , Infections dues aux prothèses/étiologie , Infections dues aux prothèses/prévention et contrôle , Violence/tendancesRésumé
We report a case of prosthetic valve endocarditis caused by Cardiobacterium hominis in a patient who had undergone atrial septal defect closure and mitral valve replacement of the heart in 1978. He presented with pyrexia of unknown origin and congestive cardiac failure. Investigations revealed infective endocarditis of prosthetic valve in mitral portion. Blood culture samples grew C. hominis. The patient was empirically started on vancomycin and gentamicin intravenously and ceftriaxone was added after isolation of the organism. Though subsequent blood cultures were negative, patient remained in congestive cardiac failure and died due to complications.
Sujets)
Antibactériens/usage thérapeutique , Cardiobacterium/effets des médicaments et des substances chimiques , Endocardite bactérienne/traitement médicamenteux , Gentamicine/usage thérapeutique , Infections bactériennes à Gram négatif/complications , Valvulopathies/traitement médicamenteux , Prothèse valvulaire cardiaque/microbiologie , Humains , Mâle , Adulte d'âge moyen , Infections dues aux prothèses/traitement médicamenteux , Vancomycine/usage thérapeutiqueRésumé
PURPOSE: Our purpose was to compare 2 methods of treatment of chronic infection in hip arthroplasties-with or without an antibiotic-loaded cement spacer. METHODS: In a prospective study, we treated 68 infected hip arthroplasties with discharging sinuses and bone loss, comparing 30 patients treated in 2 stages without the use of a spacer (control group) and 38 patients treated with a vancomycin-loaded spacer (study group). The average follow-up was 4 years (2-8.5 years). One patient died of unrelated causes 4 months after first-stage surgery and was excluded from the study. RESULTS: The 2-stage surgery without spacer controlled the infection in 66.7 percent of patients, and the 2-stage surgery using the spacer controlled it in 89.1 percent (P < 0.05). At last follow-up, the average Harris Hip Score increased from 19.3 to 69.0 in the control group versus 19.7 to 75.2 in the study group (P > 0.05). The average leg length discrepancy was 2.6 cm in the control group and 1.5 cm in the study group (P < 0.05). The patients treated with a spacer had better clinical results (81.5 percent of patients with good results against 60.0 percent for the control group). CONCLUSION: The use of an antibiotic-loaded spacer in the 2-stage treatment of infected hip arthroplasties provides better infection control with good functional results and is superior to treatment in 2 stages without a spacer. Level of Evidence: Therapeutic study, Level I-1.
OBJETIVO: As revisões em dois tempos continuam sendo os métodos preferidos no tratamento das artroplastias infectadas do quadril. O procedimento em dois estágios apresenta várias desvantagens teóricas, ainda não comprovadas por estudos comparativos. MATERIAIS E MÉTODOS: Em um estudo prospectivo, tratamos 68 pacientes com artroplastias infectadas de quadril com perdas ósseas e fístulas ativas, comparando 30 casos tratados em dois tempos sem espaçador (grupo controle) e 38 casos tratados em dois tempos com o uso de um espaçador de cimento adicionado a vancomicina (grupo de estudo). Um paciente faleceu após quatro meses da cirurgia e foi excluído do estudo. O seguimento médio foi de quatro anos (2-8,5 anos). RESULTADOS: A cirurgia em dois tempos sem espaçador controlou a infecção em 66,7 por cento dos casos comparada a 89,1 por cento (p<0,05) nos casos tratados com espaçador. No último seguimento, o Escore de Harris para Quadril passou de 19,3 a 69,0 no grupo controle e de 19,7 para 75,2 no grupo do estudo (p>0,05). A média de discrepância de membros inferiores foi de 2,6cm no grupo controle e de 1,5cm nos grupo do estudo (p<0,05). O grupo tratado com espaçador teve melhores resultados clínicos ao final do estudo (81,5 por cento de bons resultados comparados a 60,0 por cento do grupo tratado sem espaçador). CONCLUSÃO: O uso de espaçador adicionado a antibióticos no período intermediário do tratamento das artroplastias infectadas do quadril em dois tempos proporciona melhor controle de infecção, com bons resultados funcionais, sendo superior à cirurgia em dois tempos sem espaçador.
Sujets)
Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Antibactériens/usage thérapeutique , Arthroplastie prothétique de hanche/effets indésirables , Infections bactériennes/traitement médicamenteux , Ciments osseux/usage thérapeutique , Infections dues aux prothèses/traitement médicamenteux , Arthroplastie prothétique de hanche/méthodes , Infections bactériennes/étiologie , Études de suivi , Études prospectives , Défaillance de prothèse , Infections dues aux prothèses/microbiologieRésumé
Prosthetic valve infective endocarditis represents a defined pathological entity which follows an epidemiological and nosological pattern in accordance to an arbitrary classification. Chronologically it is divided into the entities of early and late prosthetic valve endocarditis, each with its own unique characteristics. The clinical features, complications and diagnosis do not vary much from native valve endocarditis. There are clear and precise indications to aid in the diagnosis and treatment of this entity which differ from native valve endocarditis
Sujets)
Humains , Valve aortique , Endocardite bactérienne/étiologie , Valve atrioventriculaire gauche , Infections dues aux prothèses , Prothèse valvulaire cardiaque/effets indésirables , Antibioprophylaxie , Antibactériens/usage thérapeutique , Échocardiographie , Échocardiographie transoesophagienne , Électrocardiographie , Endocardite bactérienne/diagnostic , Endocardite bactérienne/traitement médicamenteux , Endocardite bactérienne/microbiologie , Endocardite bactérienne/chirurgie , Infections dues aux prothèses/diagnostic , Infections dues aux prothèses/traitement médicamenteux , Infections dues aux prothèses/microbiologie , Infections dues aux prothèses/chirurgie , Facteurs de risque , Facteurs tempsRésumé
Much of the debate regarding the prophylactic use of antibiotics for patients who have had a total joint replacement has focussed on their use before dental procedures. Despite the fact that almost all orthopaedic surgeons routinely recommend antibiotics for patients with prosthetic joints who require dental treatment, there is little evidence of a definitive link between transient bacteraemia occurring during dental procedures and late infections around prosthetic joints. An extensive review of the literature reveals that most authors recommend prophylactic antibiotics in high-risk patients or in those who undergo extensive dental surgery
Sujets)
Humains , Antibioprophylaxie , Arthroplastie , Soins dentaires , Bactériémie/traitement médicamenteux , Bactériémie/épidémiologie , États-Unis/épidémiologie , Facteurs de risque , Infections dues aux prothèses/traitement médicamenteux , Infections dues aux prothèses/épidémiologie , Prémédication , Royaume-Uni/épidémiologie , Antilles/épidémiologieRésumé
En el presente trabajo se estudia la combinación amoxicilina/ßcido clavulßnico como agente que puede ser eficiente en la terapia periodontal, basßndose fundamentalmente en la revisión bibliogrßfica de comunicaciones cientÝficas; para ello se considera su efectividad clÝnica en las diferentes patologÝas periodontales, las pautas referentes a posologÝa y administración, todo lo cual contribuirß a usarlo en una forma racional, con criterio equilibrado en la terapÚutica de las periodontopatÝas
Sujets)
Humains , Association amoxicilline-clavulanate de potassium/pharmacologie , Association amoxicilline-clavulanate de potassium/usage thérapeutique , Maladies parodontales , Acide clavulanique/pharmacocinétique , Acide clavulanique/pharmacologie , Amoxicilline , Doxycycline , Association de médicaments , Bactéries à Gram négatif , Bactéries à Gram positif , Infections dues aux prothèses/traitement médicamenteux , Métronidazole , Maladies parodontales , Parodontite , Régénération tissulaire guidéeRésumé
Vancomycin has been used with increased frequency during the past 15 years and the most common toxicity with this drug is the red man syndrome . Other adverse effects include neutropenia, fever, phlebitis, nephrotoxicity, ototoxicity, thrombocytopenia, interstitial nephritis, lacrimation, linear IgA bullous dermatosis, necrotizing cutaneous vasculitis and toxic epidermal necrolysis. Only two cases of vancomycin-induced Stevens-Johnson syndrome and one case of pancytopenia have been reported in the medical literature. The treatment for both situations is based on cessation of the vancomycin therapy; in cases of Stevens-Johnson syndrome, antihistamine and/or steroid agents can be used. This article reports a case of pancytopenia and a case of erythema major associated with neutropenia.
Sujets)
Adulte , Femelle , Humains , Adulte d'âge moyen , Antibactériens/effets indésirables , Érythème , Neutropénie , Vancomycine , Anti-infectieux , Antibactériens/usage thérapeutique , Éosinophilie , Fièvre , Prothèse de hanche , Infections dues aux prothèses/traitement médicamenteux , Résistance à la méticilline , Ofloxacine , Prurit , Staphylococcus , Syndrome , VancomycineRésumé
Teicoplanin is a glycopeptide antibiotic with similar spectrum to vancomycin. However, unlike this drug, teicoplanin can be administered by i.v. or i.m. route once daily thanks to its long half-life (88 to 182 hours). This pharmacokinetic characteristic is particularly interesting in infections that require extended antimicrobial therapy, where new therapeutic strategies may be considered. Long-term treatment with teicoplanin proved effective in the treatment of bone and joint infections due to methicillin-resistant staphylococci. Teicoplanin administered three times a week yields comparable clinical efficacy than daily administration with considerably improved cost-effectiveness. This aspect merits special attention, particularly when evaluating prolonged outpatient antibiotic therapy regimens. For synergic effects it is possible to associate teicoplanin with other antibiotics. Chronic suppressive antibiotic therapy with teicoplanin may be an alternative in carefully selected patients, particularly those carrying prosthetic devices.
Sujets)
Humains , Téicoplanine/usage thérapeutique , Antibactériens/usage thérapeutique , Infections à staphylocoques/traitement médicamenteux , Infections osseuses/traitement médicamenteux , Résistance à la méticilline , Infections dues aux prothèses/traitement médicamenteux , Association de médicaments , Maladies articulaires/traitement médicamenteuxRésumé
BACKGROUND: Infection following permanent pacemaker implantation is a dreaded complication. Antibiotic prophylaxis for 1-10 days at the time of implant has been used in the past but there is no consensus regarding its duration. We carried out a prospective, randomized study of two durations of antibiotic prophylaxis to determine which one was more effective. METHODS AND RESULTS: One hundred and seventy-eight patients undergoing permanent pacemaker implantation for the first time were randomized to receive short duration (group A, n = 8 8) or longer duration (group B, n = 90) antibiotic prophylaxis for 2 days and 7 days, respectively. Patients in both groups received cloxacillin 2 g 2 hours prior to the procedure followed by ampicillin and cloxacillin (50 mg/kg/day in 4 divided doses) and gentamicin (3 mg/kg/day in 2 divided doses) for the respective duration. Patients were followed up for 1-17.3 months (9.3 +/- 1.8 months) in group A and 1-16.5 months (8.9 +/- 2 months) in group B. One patient in group B had an infection at the pacemaker site and two patients in each group had to undergo reimplantation due to pus in the pocket. There was no significant difference in the primary end-point in both groups. CONCLUSIONS: A short course (48 hours) of antibiotic prophylaxis following permanent pacemaker implantation is as effective as a longer course (7 days).
Sujets)
Antibactériens , Antibioprophylaxie/méthodes , Calendrier d'administration des médicaments , Association de médicaments/administration et posologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Pacemaker/effets indésirables , Études prospectives , Infections dues aux prothèses/traitement médicamenteuxRésumé
Para su estudio, las infecciones postartroplastía total de cadera, se dividen en superficiales y profundas, agudas y crónicas. Las infecciones agudas son aquellas que aparecen dentro de los tres primeros meses del postoperatorio; cuando son superficiales el problema se resuelve a base de limpieza quirúrgica; cuando son profundas existe un dolor intenso acompaÏado de fiebre, edema, aumento de volumen, leucocitosis y aumento en la velocidad de sedimentación globular, el tratamiento debe ser una reintervención quirúrgica inmediata. Las infecciones crónicas superficiales se han relacionado con la presencia de alambres del trocánter mayor. En la infección profunda crónica, el signo constante es el dolor, en ocasiones existe febrícula, hay aumento de volumen en muslo y cadera, la velocidad de sedimentación globular est elevada, pero la diferencial de los leucocitos es normal. A su vez las infecciones crónicas profundas se pueden subdividir en localizadas, de baja virulencia, controlables y no controlables, cada una con sus características propias y tratamiento específico.
Sujets)
Soins postopératoires , Arthroscopie , Fractures de la hanche , Infections dues aux prothèses/traitement médicamenteuxSujets)
Humains , Modèles de pratique odontologique/normes , Endocardite bactérienne/prévention et contrôle , Infections dues aux prothèses/prévention et contrôle , Endocardite bactérienne/traitement médicamenteux , Infections dues aux prothèses/traitement médicamenteux , Prothèse articulaire/effets indésirables , Arthrite/prévention et contrôleRésumé
La curación sin cirugía de la endocarditis micótica en válvula protésica es raramente descripta. Comunicamos un caso de endocarditis por Candida tropicalis sobre una prótese biológica en posición tricuspídea, en la que se consideró que la cirurgía estaba contraindicada. Se había identificado una gran vegetación sobre la prótesis biológica. Se inició tratamiento antimicótico, observándose mejoría progressiva del cuadro y desaparición de la vegetación a lo largo de 15 meses de seguimiento. El tratamiento completó 2 gr de anfotericina B para continuar luego con fluconazol. Nuestra paciente representa el primer caso de endocarditis en válvula protésica por Candida tropicalis que sobrevive sin cirugía.
Sujets)
Humains , Femelle , Adulte d'âge moyen , Amphotéricine B/usage thérapeutique , Antifongiques/usage thérapeutique , Candidose/traitement médicamenteux , Endocardite/traitement médicamenteux , Fluconazole/usage thérapeutique , Prothèse valvulaire cardiaque/microbiologie , Infections dues aux prothèses/traitement médicamenteux , Candidose/microbiologie , Endocardite/microbiologie , Prothèse valvulaire cardiaque/microbiologie , Infections dues aux prothèses/microbiologieRésumé
Si bien el falso aneurisma es una formación que no posee todas las capas de la pared arterial, su tratamiento quirúrgico es similar a los aneurismas. Se presenta nuestra experiencia quirúrgica en el tratamiento de esta patología. Se revisan en forma retrospectiva 9 pacientes operados en 53 meses. Como etiología, 6 son del tipo traumático y 3 son del tipo iatrogénico. De estos últimos, 2 son anastomáticos y uno es por punción arterial. La localización más frecuente correspondió a la arteria femoral común. El diagnóstico se confirmó con angiografía y Eco Doppler. El tratamiento quirúrgico en la mayoría fue el reemplazo arterial con vena prótesis vascular. Hubo un paciente complicado que presentó una infección de prótesis tratado sólo con antibioterapia. No hubo mortalidad. Finalmente, se concluye que esta patología es evitable a través de un equipo entrenado en trauma vascular, el evitar el uso de prótesis vascular y una buena técnica quirúrgica